Bausch Health Cos (NYSE:BHC) Sees Unusually-High Trading Volume – What’s Next?

Shares of Bausch Health Cos Inc. (NYSE:BHC) saw unusually-high trading volume on Tuesday . Approximately 4,983,626 shares were traded during mid-day trading, an increase of 98% from the previous session’s volume of 2,521,238 shares.The stock last traded at $6.2040 and had previously closed at $6.11.

Wall Street Analysts Forecast Growth

BHC has been the subject of a number of recent research reports. Wall Street Zen upgraded shares of Bausch Health Cos from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 1st. Weiss Ratings reissued a “hold (c)” rating on shares of Bausch Health Cos in a report on Wednesday, October 8th. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $9.00.

Bausch Health Cos Price Performance

The company has a market capitalization of $2.32 billion, a PE ratio of 24.06 and a beta of 0.47. The company has a quick ratio of 0.98, a current ratio of 1.31 and a debt-to-equity ratio of 141.90. The firm’s 50-day moving average is $6.41 and its 200-day moving average is $6.29.

Hedge Funds Weigh In On Bausch Health Cos

Large investors have recently modified their holdings of the company. Federated Hermes Inc. bought a new stake in Bausch Health Cos in the 1st quarter worth approximately $758,000. XTX Topco Ltd bought a new stake in shares of Bausch Health Cos in the 1st quarter worth approximately $139,000. Wealthquest Corp bought a new stake in shares of Bausch Health Cos in the 1st quarter worth approximately $58,000. Cary Street Partners Financial LLC bought a new position in shares of Bausch Health Cos during the 1st quarter valued at $27,000. Finally, Vanguard Group Inc. grew its holdings in shares of Bausch Health Cos by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 11,746,480 shares of the company’s stock valued at $76,152,000 after purchasing an additional 61,621 shares during the last quarter. 78.65% of the stock is owned by hedge funds and other institutional investors.

About Bausch Health Cos

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.